西罗莫司自乳化给药系统及其固体化研究

刘志宏; 胡雄伟; 陶春; 张晶; 宋洪涛; 刘志宏; 胡雄伟; 陶春; 张晶; 宋洪涛

doi:10.3969/j.issn.1006-0111.2016.02.012

[1]

Rial MC,Abbud-Filho M,Goncalves RT,et al. Individualizing early use of sirolimus in renal transplantation[J]. Transplant Proc,2010,42(10):4518-4525.

[2]

Toso C,Merani S,Bigam DL,et al. Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma[J].Hepatology,2010,51(4):1237-1243.

[3]

Chatel MA,Larkin DF. Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk[J]. Am J Ophthalmol,2010,150(2):179-184.

[4]

Chen Y,Li G,Wu X,et al. Self-microemulsifying drug delivery system(SMEDDS)of vinpocetine:formulation development and in vivo assessment[J]. Biol Pharm Bull,2008,31(1):118-125.

[5]

Patel AR,Vavia PR. Preparation and in vivo evaluation of SMEDDS(self-microemuldifying drug delivery system)containing fenofibrate[J].AAPS J,2007,9(3):344-352.

[6]

Woo JS,Song YK,Hong JY,et al. Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers[J]. Eur J Pharm Sci,2008,33(2):159-165.

[7]

温许,黄爱文,张敏新,等. 西罗莫司固体自微乳口服缓释微丸的制备与体外释药考察[J]. 中国医院药学杂志,2014,34(23):1998-2003.